Sugi Predict

Sugi Predict / Compounds / SCHEMBL15030823

SCHEMBL15030823

SCHEMBL15030823

Cc1ccccc1-c1ccc2c(c1)C1(c3ccccc3Oc3ccccc31)c1cc(-c3ccccc3C)ccc1N2c1ccc2ccc3c(N4c5ccc(-c6ccccc6C)cc5C5(c6ccccc6Oc6ccccc65)c5cc(-c6ccccc6C)ccc54)ccc4ccc1c2c43

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 1/20 0.36
▸ CTSD P07339 2/20 0.36
▸ BACE1 P56817 2/20 0.36
▸ CLK4 Q9HAZ1 8/20 0.33
▸ CYP2C19 P33261 6/20 0.33
▸ TSHR P16473 6/20 0.33
▸ ALDH1A1 P00352 6/20 0.33
▸ MAPK1 P28482 4/20 0.33
▸ HIF1A Q16665 2/20 0.33
▸ CYP1A2 P05177 7/20 0.33
▸ CYP3A4 P08684 7/20 0.33
▸ CYP2D6 P10635 5/20 0.33
▸ CYP2C9 P11712 2/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ LMNA P02545 3/20 0.32
▸ USP2 O75604 3/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ HSD17B10 Q99714 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15030830 0.97 PDK2 (0.34) PDK2CTSDBACE1CLK4CYP2C19
SCHEMBL15030835 0.81 PDK2 (0.37) PDK2CTSDBACE1CA12CA9
SCHEMBL15030803 0.81 KDM4E (0.33) ALDH1A1MAPK1KMT2A
SCHEMBL15030887 0.81 PDK2 (0.35) PDK2CTSDBACE1CA12CA9
SCHEMBL15030672 0.80 HTR7 (0.40) PDK2CTSDBACE1CLK4CYP2C19
SCHEMBL15030726 0.80 PDK2 (0.38) PDK2CTSDBACE1CLK4CYP2C19
SCHEMBL15030729 0.79 CTSD (0.33) PDK2CTSDBACE1CA12CA9
SCHEMBL15030874 0.78 ALDH1A1 (0.40) TSHRALDH1A1MAPK1CYP1A2CYP3A4
SCHEMBL16186699 0.77 CTSD (0.41) PDK2CTSDBACE1CLK4CYP2C19
SCHEMBL15030828 0.76 CTSD (0.35) PDK2CTSDBACE1CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10305040-B2 Spiro dihydroacridine derivatives and the use thereof as materials for organic electroluminescence devices MERCK PATENT GMBH (DE) 2019-05-28 — — US disclosed
EP-2780325-B1 SPIRO-DIHYDROACRIDINE DERIVATIVES AND THEIR USE AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2016-02-03 — — EP disclosed
US-20140316134-A1 SPIRO DIHYDROACRIDINE DERIVATIVES AND THE USE THEREOF AS MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2014-10-23 — — US disclosed
US-20140316134-A1 SPIRO DIHYDROACRIDINE DERIVATIVES AND THE USE THEREOF AS MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2014-10-23 — — US disclosed
WO-2013083216-A1 SPIRO DIHYDROACRIDINE DERIVATIVES AND THE USE THEREOF AS MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2013-06-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10305040-B2 Spiro dihydroacridine derivatives and the use thereof as materials for organic electroluminescence devices SORD, ALDH1A1, SDHA PDK2 202/4885CTSD 1951/4885BACE1 4585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.